The mechanistic target of rapamycin inhibitors (mTORi) sirolimus and everolimus stabilize lung...
Read More
Cytomegalovirus (CMV) infection may complicate ulcerative colitis (UC) or Crohn’s disease...
Read More
Intestinal fibrosis is a common outcome of inflammatory bowel diseases (IBDs), becoming clinically...
Read More
The aim was to investigate SNPs of TLR-2,3,4, NOD2/CARD15, JAK-2, and IL-10 in patients with the...
Read More
Pareneteral manifestations of Crohn’s disease (ChLC), apart from the most common skin and...
Read More
This study sought to isolate active Flos lonicerae flavonoids and evaluate their anti-oxidative...
Read More
The diagnostic assessment of liver injury is an important step in the management of patients with...
Read More
Elimination of chronic hepatitis C (HCV) will require scaling up treatment, including possible HCV...
Read More
By Babak Dehghanpisheh DUBAI (Reuters) – Coronavirus has spread to almost all of...
Read More
Systematically assess studies that have analyzed the psychometric properties of multichannel...
Read More
Guidelines suggest endoscopic screening of individuals who are at increased risk for...
Read More
Eosinophilic esophagitis (EE) is a chronic immune/antigen-mediated esophageal inflammatory disease...
Read More
Impaired esophageal motility and disrupted esophagogastric junction (EGJ) on highresolution...
Read More
Acid suppression therapy (AST), composed of proton pump inhibitors (PPIs), histamine-2 receptor...
Read More
Colorectal cancer is one of the most important common malignancies; therefore, timely screening...
Read More
Gastrointestinal Dieulafoy’s ulcer is a rare disease of unknown etiology. Dieulafoy’s...
Read More
The current gold standard diagnostic test for colorectal cancer remains histological inspections...
Read More
Colorectal cancer is a common malignancy. NTS receptor 3 (NTSR3) plays an important part in...
Read More
A trend of increasing incidence of colorectal cancer (CRC) has been observed in northern Tanzania....
Read More
The use of ipilimumab, nivolumab, and pembrolizumab as monotherapies or in combination has...
Read More
